---
$id: https://graph.org.ai/products/commodity/51282943
$type: Product
source: UNSPSC
code: "51282943"
title: "Rufloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rufloxacin

**UNSPSC Code**: 51282943
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C17H18FN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y521XM2900, chemically known as 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid but generally known as rufloxacin, which bears US NIH Compound Identifier 58258. European Medicines Agency schedules Rufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10404MIG. The term RUFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules rufloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. RUFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rufloxacin under HS 29349990 and SITC 51579. As of Q4 2014, RUFLOXACIN remains the US FDA Preferred Term for this commodity. Rufloxacin bears US NLM identifiers UMLS ID C0073704 and NCI Concept Code C72638. SMILES: S1C2C(N3CCN(CC3)C)C(F)CC3C2N(CC1)CC(C3=O)C(=O)O.

